Visionflex Group Limited (ASX: VFX) - Share Price
- Current share price for VFX : $0.040
Visionflex Group Limited (VFX) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is a Company that is engaged in provision of healthcare, telehealth, and remote diagnostic solutions into both local and international markets.
VFX General Information +
| ASX Code | VFX |
| Website | http://www.vfx-group.com |
| Industry/Sector | Health Care Technology |
| Market Cap ($M) | 3 |
| VFX Share Price | $0.040 |
| Day High | $0.040 |
| Day Low | $0.040 |
| Last Close | $0.040 |
| VFX Share Price Movement | - ( No change ) |
Prices as at 12:20, 25 Sep 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
Visionflex Group Limited (VFX) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|
See all dividends from Visionflex Group Limited (VFX) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Visionflex Group Limited (VFX) price-sensitive announcements
VFX - Q4 FY26 Quarterly Activity Report
Visionflex Group Limited reported a successful Q4 FY26 with positive cash flow and strateg
Visionflex Group Limited (VFX)
13 Jul 2026 | 9:04 AM
13 Jul 2026 | 9:04 AM
VFX - Q4 FY26 Appendix 4C
The document is the Q4 FY26 Appendix 4C report for Visionflex Group Limited, detailing the
Visionflex Group Limited (VFX)
13 Jul 2026 | 9:03 AM
13 Jul 2026 | 9:03 AM
VFX - Visionflex Awarded NSW Health Contract to Supply Hardware
Visionflex Group Limited has been awarded a contract by NSW Health to supply approximately
Visionflex Group Limited (VFX)
26 Jun 2026 | 8:18 AM
26 Jun 2026 | 8:18 AM
VFX - Q3 FY26 Appendix 4C
The Q3 FY26 Appendix 4C report for Visionflex Group Limited details the company's financia
Visionflex Group Limited (VFX)
29 Apr 2026 | 8:45 AM
29 Apr 2026 | 8:45 AM
Visionflex Group Limited (VFX) Recent ASX Announcements
VFX Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2026A | -$0.01 | N2 | -99.80% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2025A | -$3.21 | -$5.20 | -4.10% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2024A | -$1.53 | -$5.40 | -52.80% | 0.00 | 0.00 | 0.00% | 0.0% |
VFX Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 A | 2025 A | 2026 A | 2024 A | 2025 A | 2026 A | 2024 A | 2025 A | 2026 A | ||
| 4DMedical Limited (4DX) | $2,454M | 1.4982 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Artrya Limited (AYA) | $632M | -0.0450 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Pro Medicus Limited (PME) | $16,852M | 1.3034 | -0.2811 | 0.2395 | 63.6080 | 88.4812 | 71.3824 | 0.43% | 0.57% | 0.71% |
| Visionflex Group Limited (VFX) | $3M | -0.9981 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
VFX Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.00 | 0.00 | -200.00 | 0.00 |
| Market | 0.33 | 13.80 | 1.17 | 0.79 |
| Sector | 0.66 | 20.70 | 1.79 | 2.52 |
VFX Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Joshua Luke Mundey | Chief Executive Officer, Managing Director | 1 Mar 2025 |
| Mr Michael Kafrouni | Chief Operating Officer, Executive Director | 1 Mar 2025 |
| Mr Brook Adcock | Non-Executive Director, Interim chairman | 17 Jun 2022 |
Visionflex Group Limited (VFX) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 19 Nov 2025 | ADCOCK, Brook | Issued | Indirect Shares | 139,831,500 | $0.004 | $559,326.000 |
| 25 Jul 2024 | WHITEHEAD, Christopher (Chris) | Issued | Direct Shares | 2,493,080 | $0.005 | $12,465.400 |
| 25 Jul 2024 | NEATE, Geoffrey | Issued | Indirect Shares | 9,948,814 | $0.005 | $49,744.070 |
See all changes in directors' interest & trades for Visionflex Group Limited (VFX) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
VFX Management
| Name | Position |
|---|---|
| James Aulsebrook | Chief Financial Officer |
| Maria Clemente | Company Secretary |
VFX Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Visionflex Group Limited (VFX). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 1,129,621,510 (33.67%) | John Charles Plummer |
| 851,431,604 (25.38%) | Adcock Private Equity Pty Limited |
| 197,583,046 (5.89%) | Michael John Harman |
VFX Calendar of Events
| Date | Event |
|---|---|
| 27 August 2027 | Report (Annual) |
| 27 August 2027 | Report (Prelim) |
| 25 February 2027 | Report (Interim) |
| 19 November 2026 | AGM |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
